Do beta-blockers reduce my risk of death if my heart function is normal after MI?
Beta-blockers have long been standard after a heart attack (myocardial infarction, or MI). However, most of the original studies were done before modern treatments like stents, statins, and blood thinners were routine. If your heart's pumping ability (ejection fraction) is normal — usually 50% or higher — the question is whether beta-blockers still help you live longer. Recent large trials suggest they may not provide a clear survival benefit in this group.
What the research says
A 2024 trial published in the New England Journal of Medicine randomly assigned over 5,000 patients who had an MI and a left ventricular ejection fraction of at least 50% to receive a beta-blocker (metoprolol or bisoprolol) or no beta-blocker. After about 3.5 years, the rate of death or new heart attack was nearly identical: 7.9% in the beta-blocker group versus 8.3% in the no-beta-blocker group, a difference that was not statistically significant 9. Another 2024 trial tested whether patients with an ejection fraction of 40% or higher could safely stop long-term beta-blocker therapy. It found that stopping beta-blockers was not inferior to continuing them for the combined outcome of death, heart attack, stroke, or hospitalization for cardiovascular reasons 10. A meta-analysis of five randomized controlled trials (over 23,500 patients) with preserved ejection fraction (≥40%) found that beta-blockers did not significantly reduce all-cause mortality (hazard ratio 0.97), recurrent heart attack (0.89), or heart failure (0.92) 3. However, a broader meta-analysis that included observational studies (over 290,000 patients) found an 11% reduction in all-cause mortality with beta-blocker use, but this benefit disappeared when the analysis was limited to patients with preserved ejection fraction (hazard ratio 0.99) 11. Taken together, the best available evidence from randomized trials indicates that for patients with normal or near-normal heart function after an MI, beta-blockers do not clearly lower the risk of death or future heart attacks.
What to ask your doctor
- What is my current left ventricular ejection fraction (LVEF) and does it fall into the preserved range (≥50%)?
- Given my specific heart function and other risk factors, do you recommend I continue or stop beta-blocker therapy?
- Are there any side effects from beta-blockers (like fatigue or low blood pressure) that I should watch for?
- How do my other medications (like statins or antiplatelet drugs) affect the decision about beta-blockers?
- If I stop beta-blockers, what symptoms should prompt me to seek medical attention?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.